Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer

Showing 15 posts of 894 posts found.

Pfizer to invest $200m in Irish biomanufacturing plant

September 21, 2011
Manufacturing and Production Ireland, Pfizer, pharma manufacturing news

Pfizer is planning to invest around €145 million ($200m) at its biomanufacturing facility in Co Dublin, Ireland, according to the …

News
Pfizer Sandwich Kent

Ex-Pfizer employees set up new business at Sandwich

September 1, 2011
Research and Development Pfizer, Sandwich, The Research Network, research and development news

Seven former Pfizer employees have set up a new business in Sandwich that will provide outsourcing services for the pharma …

News

FDA approves Pfizer’s lung cancer drug Xalkori

August 30, 2011
Sales and Marketing FDA, Pfizer, Xalkori, crizotinib

Pfizer’s lung cancer drug Xalkori has been approved by the FDA, a month ahead of schedule. Xalkori (crizotinib) is now …

News
Pfizer

EMA to review two new Pfizer cancer drugs

August 19, 2011
Sales and Marketing Cancer, Pfizer, bosutinib, crizotinib

The EMA has accepted Pfizer’s regulatory submissions for two of its new cancer compounds. The first is its much-lauded crizotinib, …

News

Pfizer triumphs in US Viagra patent trial

August 17, 2011
Sales and Marketing Pfizer, generics, viagra

Pfizer has won a US patent infringement case against generics giant Teva, stopping the company from making its own version …

News

Online learning for non-medical prescribers launched

August 12, 2011
Medical Communications Pfizer, Prescriber, medical education, non medical prescribing

Therapeutics PLUS, a free online medical education offering to healthcare professionals has been re-launched. The online resource has been created …

News
Kano, Nigeria, drug trial

Pfizer pays compensation to Nigerian trial victims

August 12, 2011
Kano, Pfizer, Trovan, misconduct, out of court

Pfizer has paid out the first compensation to families of children who died during a meningitis drug trial in Nigeria. …

News

Pfizer teams up with University of California for drug discovery

August 9, 2011
Research and Development, Sales and Marketing Pfizer, academic research

Pfizer has signed a deal with the University of California to help expand its drug discovery and development programme. The …

News

Mergers and spending cuts damaging drug research

August 3, 2011
Research and Development, Sales and Marketing LaMattina, Pfizer, research productivity

Big pharma’s policy of mergers and swingeing cuts is having a devastating effect on drug research, says a former Pfizer …

News
Pfizer HQ

Pfizer looks to spin off animal health and nutrition

August 2, 2011
Sales and Marketing Pfizer, Q2, animal health, divestment, nutrition

Pfizer looks set to spin-off or sell its animal health and nutrition business units in order to focus on human …

News
Pfizer's hacked Facebook page

Digital Pharma: Pfizer’s Facebook page hacked

July 22, 2011
Medical Communications Digital Pharma blog, Facebook, Pfizer

Pfizer has regained control of its corporate Facebook page after hackers temporarily defaced it earlier this week. A UK group …

News

Pfizer’s ageing blockbuster Lipitor wins $770m paediatric boost

July 11, 2011
Sales and Marketing Lipitor, Pfizer, paediatric trials

Pfizer has been given more time to sell its anti-cholesterol treatment Lipitor exclusively in Europe as a quid pro quo …

News

Pfizer sharpens its pharma focus

July 8, 2011
Sales and Marketing Pfizer, animal health, nutrition, pharma strategy

Pfizer has given its strongest signal yet that its animal health and nutrition arms do not have long to last …

News
Pfizer

Study claims cardiovascular risk to Pfizer’s Champix

July 6, 2011
Research and Development, Sales and Marketing Champix, Chantix, Pfizer, smoking cessation

Pfizer has been drawn into a war of words over its smoking cessation drug Champix after a review of existing …

News

Pfizer re-acquires Rouses Point from Akrimax

July 5, 2011
Manufacturing and Production Pfizer, pharma manufacturing news

Pfizer has decided to buy back a manufacturing facility in Rouses Point, New York, from current owner Akrimax Pharmaceuticals, and …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026